NOVATED, AMENDED AND RESTATED LICENSE AGREEMENT by and between ARGOS THERAPEUTICS, INC., MEDINET CO., LTD. and MEDCELL CO., LTD.License Agreement • March 31st, 2015 • Argos Therapeutics Inc • Pharmaceutical preparations • New York
THIS NOVATED, AMENDED AND RESTATED LICENSE AGREEMENT (the “Agreement”), effective as of October 1, 2014 (the “Effective Date”), is by and between Argos Therapeutics, Inc., a corporation organized and existing under the laws of Delaware (“Argos”), Medinet Co., Ltd., a corporation organized and existing under the laws of Japan (“Medinet”) and MEDcell Co., Ltd., a corporation organized and existing under the laws of Japan.
DEVELOPMENT AGREEMENTDevelopment Agreement • March 31st, 2015 • Argos Therapeutics Inc • Pharmaceutical preparations • New York
This Development Agreement (the “Agreement”) is entered by and between SAINT-GOBAIN PERFORMANCE PLASTICS CORPORATION, a California corporation having an office at 1199 South Chillicothe Road, Aurora, OH 44202 (“SGPPL”), and ARGOS THERAPEUTICS, INC., a Delaware corporation having an office at 4233 Technology Drive, Durham, NC 27704 (“Argos”), as of the 5th day of January 2015 (the “Effective Date”). SGPPL and Argos are hereafter referred to collectively as the “Parties,” “Other Party,” or individually as a “Party”, as applicable.
